MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Read More…
Industry, Sector and Symbol
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Phone615-627-4710
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$57.26 million
Profitability
Miscellaneous
Employees11
Next Earnings DateN/A
OptionableNot Optionable
MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions
What is MedEquities Realty Trust's stock symbol?
MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT."
How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust?
MedEquities Realty Trust announced a dividend on Wednesday, January 2nd. Investors of record on Monday, March 11th will be paid a dividend of $0.21 per share on Wednesday, May 15th. The ex-dividend date is Thursday, May 16th. View MedEquities Realty Trust's Dividend History.
How were MedEquities Realty Trust's earnings last quarter?
MedEquities Realty Trust Inc (NYSE:MRT) released its quarterly earnings results on Wednesday, August, 8th. The financial services provider reported $0.10 EPS for the quarter, missing the consensus estimate of $0.30 by $0.20. The financial services provider earned $17.56 million during the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a return on equity of 1.01% and a net margin of 3.24%. View MedEquities Realty Trust's Earnings History.
What price target have analysts set for MRT?
6 brokerages have issued 1-year price targets for MedEquities Realty Trust's stock. Their forecasts range from $9.00 to $12.00. On average, they expect MedEquities Realty Trust's stock price to reach $10.20 in the next year. View Analyst Price Targets for MedEquities Realty Trust.
What is the consensus analysts' recommendation for MedEquities Realty Trust?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MedEquities Realty Trust.
Has MedEquities Realty Trust been receiving favorable news coverage?
News articles about MRT stock have been trending negative this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. MedEquities Realty Trust earned a news impact score of -2.3 on InfoTrie's scale. They also assigned media headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for MedEquities Realty Trust.
Who are some of MedEquities Realty Trust's key competitors?
Some companies that are related to MedEquities Realty Trust include Brookfield Property Reit (BPR), Tanger Factory Outlet Centers (SKT), Industrial Logistics Properties Trust (ILPT), Interrent Real Estate Investment Trust (IIPZF), Universal Health Realty Income Trust (UHT), American Finance Trust (AFIN), Monmouth R.E. Inv. (MNR), Kite Realty Group Trust (KRG), Independence Realty Trust (IRT), Summit Hotel Properties (INN), Saul Centers (BFS), ARBOR RLTY TR I/SH (ABR), KKR Real Estate Finance Trust (KREF), NexPoint Residential Trust (NXRT) and Granite Point Mortgage Trust (GPMT).
What other stocks do shareholders of MedEquities Realty Trust own?
Who are MedEquities Realty Trust's key executives?
MedEquities Realty Trust's management team includes the folowing people:
- Mr. John W. McRoberts, Chairman & CEO (Age 66)
- Mr. William C. Harlan, Pres, COO & Director (Age 67)
- Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 49)
- Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 44)
- Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC
When did MedEquities Realty Trust IPO?
(MRT) raised $259 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 19,900,000 shares at a price of $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers.
How do I buy shares of MedEquities Realty Trust?
Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How big of a company is MedEquities Realty Trust?
What is MedEquities Realty Trust's official website?
How can I contact MedEquities Realty Trust?
MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected]
MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)
MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
